Evidence map›Paper›PMID 36846798›Full record

ArticleFrontiers in microbiology2023

Amoxicillin-docosahexaenoic acid encapsulated chitosan-alginate nanoparticles as a delivery system with enhanced biocidal activities against

Saeed Khoshnood, Babak Negahdari, Vahab Hassan Kaviar, Nourkhoda Sadeghifard, Mohd Azmuddin Abdullah, Mohamed El-Shazly, Mohammad Hossein Haddadi

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Novel Drug Delivery Systems for CombatingArchives of Razi Institute · 2024
    Review
  8. Review
  9. Review
  10. Article
  11. Frontiers in microbiology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Saeed KhoshnoodClinical Microbiology Research Centre, Ilam University of Medical Sciences, Ilam, Iran.
Babak NegahdariDepartment of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Vahab Hassan KaviarClinical Microbiology Research Centre, Ilam University of Medical Sciences, Ilam, Iran.
Nourkhoda SadeghifardClinical Microbiology Research Centre, Ilam University of Medical Sciences, Ilam, Iran.
Mohd Azmuddin AbdullahDepartment of Toxicology, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Penang, Malaysia.
Mohamed El-ShazlyDepartment of Pharmacognosy, Faculty of Pharmacy, Ain-Shams University, Cairo, Egypt.
Mohammad Hossein HaddadiClinical Microbiology Research Centre, Ilam University of Medical Sciences, Ilam, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Encapsulation of amoxicillin (AMX) for drug delivery against

Indexed as

amoxicillinbiocidal activitieschitosanchitosan-DHA nanoparticlesdocosahexaenoicencapsulationHelicobacter pylori

Identifiers

PMID36846798
PMCPMC9948253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.